Spike-specific humoral and cellular immune responses after COVID-19 mRNA vaccination in patients with cirrhosis: A prospective single center study
- 17 October 2022
- journal article
- research article
- Published by Elsevier in Digestive and Liver Disease
- Vol. 55 (2) , 160-168
Abstract
No abstract availableKeywords
Funding Information
- National Research Foundation (NRF-000230-00, NRF-CRP25-2020-0003)
- National Medical Research Council (MOH-000019, MOHStaR17Nov-0001)
- Government of Singapore Ministry of Health
- National Research Foundation
- Ministero della Salute
This publication has 25 references indexed in Scilit:
- Predictors of Outcomes of COVID-19 in Patients With Chronic Liver Disease: US Multi-center StudyClinical Gastroenterology and Hepatology, 2021
- Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry studyJournal of Hepatology, 2021
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UKThe Lancet, 2021
- High rates of 30-day mortality in patients with cirrhosis and COVID-19Journal of Hepatology, 2020
- Characteristics of SARS-CoV-2 and COVID-19Nature Reviews Microbiology, 2020
- SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19Nature, 2020
- SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controlsNature, 2020
- Effectiveness of influenza vaccines in adults with chronic liver disease: a systematic review and meta-analysisBMJ Open, 2019
- Response to hepatitis B vaccination in patients with liver cirrhosisReviews in Medical Virology, 2017
- Pneumococcal Vaccine Response in Cirrhosis and Liver TransplantationThe Journal of Infectious Diseases, 2000